Publicaciones en las que colabora con Lara González Freire (11)
2023
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
2022
-
Development of a carbocysteine 10% + urea 5% cream for the topical treatment of congenital ichthyosis
Farmacia Hospitalaria, Vol. 46, Núm. 2, pp. 51-56
-
Tratamiento de la eritrodisestesia palmoplantar con una fórmula magistral de urea 20% + triamcinolona acetónido 0, 2% + lidocaína 2%
Ilaphal. Revista de la OFIL, Vol. 32, Núm. 3, pp. 301-303
2021
-
Baricitinib and tofacitinib in patients with rheumatoid arthritis: results of regular clinical practice
Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 165-169
-
Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice
Clinical Therapeutics, Vol. 43, Núm. 4, pp. e111-e121
-
Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis
Farmacia Hospitalaria, Vol. 45, Núm. 2, pp. 73-76
2020
-
Re-initiation of treatment with sargramostim in a patient with pulmonary alveolar proteinosis
European Journal of Clinical Pharmacy, Vol. 22, Núm. 3, pp. 175-177
2018
-
Anakinra for the treatment of undifferentiated systemic auto-inflammatory disease
European Journal of Clinical Pharmacy, Vol. 20, Núm. 6, pp. 337-339
-
Use of plasma exchange as therapeutic tool in clinical practice
Farmacia Hospitalaria, Vol. 42, Núm. 1, pp. 16-19
-
pH determination as a quality standard for the elaboration of oral liquid compounding formula
Farmacia Hospitalaria, Vol. 42, Núm. 6, pp. 221-227
2017
-
Contralateral choroiditis secondary to combination therapy with simeprevir, sofosbuvir and ribavirin
European Journal of Clinical Pharmacy, Vol. 19, Núm. 4, pp. 291-293